Osteoporosis Biosimilar OK’d; New Endo Guidelines; A Hot Spot for Stealing Ozempic
MedPage Today) -- The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture and increasing bone...
Arden Stoval
